2015
DOI: 10.2298/vsp140531067s
|View full text |Cite
|
Sign up to set email alerts
|

The significance of adiponectin as a biomarker in metabolic syndrome and/or coronary artery disease

Abstract: The obtained resultats suggest that adiponectin may be a useful marker in identification of individuals with risk of developing metabolic syndrome and coronary artery disease, as well as a predictor of prediabetes.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
12
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 20 publications
(16 citation statements)
references
References 0 publications
4
12
0
Order By: Relevance
“…Moreover, multiple regression analyses by gender showed that ischemic stroke was more likely to affect the males with MUNO, whereas it was more likely to affect the females with MUNO or MUO. These results indicate that metabolism and not obesity itself causes CVD, in agreement with other studies (Millan-Nunez et al 2016; Stojanović et al 2015; Turker et al 2015). However, the differing results according to gender require further investigation.…”
Section: Discussionsupporting
confidence: 92%
“…Moreover, multiple regression analyses by gender showed that ischemic stroke was more likely to affect the males with MUNO, whereas it was more likely to affect the females with MUNO or MUO. These results indicate that metabolism and not obesity itself causes CVD, in agreement with other studies (Millan-Nunez et al 2016; Stojanović et al 2015; Turker et al 2015). However, the differing results according to gender require further investigation.…”
Section: Discussionsupporting
confidence: 92%
“…Adiponectin levels are lower in patients with essential hypertension and type-2 diabetes, and adiponectin is associated with insulin resistance, triglycerides and HDL cholesterol levels (Lihn, Pedersen, & Richelsen, 2005;Nigro et al, 2014;Vaiopoulos, Marinou, Christodoulides, & Koutsilieris, 2012). Given its role in metabolic diseases, adiponectin may be important in tracking and diagnosing some of the most rapidly growing and costly diseases in the United States (e.g., prediabetes/insulin resistance, metabolic syndrome, and vascular disease; Ebrahimi-Mamaeghani, Mohammadi, Arefhosseini, Fallah, & Bazi, 2015;Lopez-Jaramillo et al, 2014;Stojanović, Ilić, Ilić, Petrović, & Djukić, 2015).…”
Section: Introductionmentioning
confidence: 99%
“…This observation is in concordance with previous data. It was demonstrated that lowlevel adiponectin subjects were characterized by a significantly higher prevalence of some cardiometabolic comorbidities (obesity, visceral obesity, DM, insulin resistance, LV hypertrophy, metabolic syndrome, CAD) [26,31,32].…”
Section: Discussionmentioning
confidence: 99%